We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.04B
AUM Growth
-$134M
Cap. Flow
-$160M
Cap. Flow %
-15.32%
Top 10 Hldgs %
17.93%
Holding
1,138
New
391
Increased
229
Reduced
281
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 15.26%
2 Financials 13.67%
3 Healthcare 9.75%
4 Industrials 9.11%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTR
826
DELISTED
CytRx Corp
CYTR
$7K ﹤0.01%
+3,237
New +$9.52K
ADPT
827
DELISTED
ADPT Corp
ADPT
$7K ﹤0.01%
+968
New +$7K
JMBA
828
DELISTED
Jamba, Inc.
JMBA
$7K ﹤0.01%
+700
New +$7.25K
AGEN
829
Agenus
AGEN
$312M
$6K ﹤0.01%
+74
New +$7.27K
ATRA icon
830
Atara Biotherapeutics
ATRA
$73.9M
$6K ﹤0.01%
+18
New +$7.62K
AVXL icon
831
Anavex Life Sciences
AVXL
$303M
$6K ﹤0.01%
+1,490
New +$5.31K
BSET icon
832
Bassett Furniture
BSET
$174M
$6K ﹤0.01%
+185
New +$5K
CTMX icon
833
CytomX Therapeutics
CTMX
$734M
$6K ﹤0.01%
+541
New +$6.55K
TDAY
834
USA Today Co
TDAY
$1.19B
$6K ﹤0.01%
+348
New +$5.37K
NVAX icon
835
Novavax
NVAX
$1.25B
$6K ﹤0.01%
+258
New +$7.53K
RBBN icon
836
Ribbon Communications
RBBN
$381M
$6K ﹤0.01%
+916
New +$6.02K
RPD icon
837
Rapid7
RPD
$692M
$6K ﹤0.01%
+492
New +$6.66K
TPST icon
838
Tempest Therapeutics
TPST
$14.6M
$6K ﹤0.01%
+1
New +$12.5K
VANI icon
839
Vivani Medical
VANI
$117M
$6K ﹤0.01%
+124
New +$7.08K
XENT
840
DELISTED
Intersect ENT, Inc
XENT
$6K ﹤0.01%
+482
New +$6.24K
XLRN
841
DELISTED
Acceleron Pharma
XLRN
$6K ﹤0.01%
+248
New +$7.86K
FLXN
842
DELISTED
Flexion Therapeutics, Inc.
FLXN
$6K ﹤0.01%
+316
New +$6.04K
KDMN
843
DELISTED
Kadmon Holdings, Inc.
KDMN
$6K ﹤0.01%
+1,036
New +$5.82K
FSB
844
DELISTED
Franklin Financial Network, Inc.
FSB
$6K ﹤0.01%
+155
New +$5.64K
PGNX
845
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$6K ﹤0.01%
+639
New +$4.72K
PETX
846
DELISTED
Aratana Therapeutics, Inc.
PETX
$6K ﹤0.01%
+873
New +$7.06K
ANTH
847
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$6K ﹤0.01%
+1,197
New +$20.7K
NMBL
848
DELISTED
Nimble Storage, Inc.
NMBL
$6K ﹤0.01%
+743
New +$6.06K
FNSR
849
DELISTED
Finisar Corp
FNSR
$6K ﹤0.01%
+204
New +$6.26K
DDS icon
850
Dillards
DDS
$9.66B
$5K ﹤0.01%
+85
New +$5.58K

Similar funds

Meeder Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, Meeder Asset Management held 1,138 positions worth $1.04B, down 11% from $1.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Meeder Asset Management withdrew a net $160M in Q4 2016, closing 148 positions and reducing 281 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $74.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Meeder Asset Management opened a new position in iShares Core US Aggregate Bond ETF worth $17.1M.

  • Meeder Asset Management's largest Q4 2016 buy was iShares Core US Aggregate Bond ETF: 157,897 shares worth $17.1M.
  • Meeder Asset Management added most to Time Warner Inc in Q4 2016, an estimated $4.76M increase.
  • Meeder Asset Management's biggest Q4 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $43.5M.
  • Meeder Asset Management fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $74.7M.
  • Meeder Asset Management's ten largest holdings make up 18% of its $1.04B portfolio in Q4 2016.
  • Meeder Asset Management opened 391 new positions and closed 148 in Q4 2016.
  • Meeder Asset Management's portfolio value fell 11% quarter-over-quarter to $1.04B.

Based on Meeder Asset Management's 13F filing for Q4 2016, filed 11 Jan 2017.